Find activities

2 results

  • Topical corticosteroids: Proposal for the package labelling to state their potency

    Medsafe is seeking your feedback on a proposed advisory statement for topical corticosteroids to include information about the potency (strength) on the container/package label. In March 2025, the Medicines Adverse Reactions Committee (MARC) reviewed the risk of topical steroid withdrawal reactions . The MARC commented that inappropriate overuse of topical corticosteroids is common and noted the recent action taken by the United Kingdom’s medicines regulator, the Medicines... More
    Opened 16 June 2025

  • Proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Bioequivalence of medicines

    This consultation is aimed at pharmaceutical companies seeking to demonstrate bioequivalence of medicines to support applications to Medsafe for regulatory approval of new and changed products. Prescribers and healthcare professionals with an interest in medicine regulation, in particular generic medicine approval, may also wish to participate. Medsafe is seeking your feedback on changes to the Guideline on the Regulation of Therapeutic Products in New Zealand: Part 6: Bioequivalence... More
    Opened 9 June 2025
2 results. Page 1 of 1